BIOTECH CONSORTIUM

INDIA LIMITED (BCIL)

KALLOLI CHATTERJEE B191094

ALISHA DABADE. B191068
PRANALI YADAV B191069
PRAPTI KAMBLE B191055
JUHI CHURI - B191035
ADITI PAWAR- B191058
SANIKA GHODEKAR - B191031
BHAGYASHREE GARUD - B191032
PRANITA BAMBLE B191023
AKANKSHA IDHATE - B191092
SIDDHI TUPE B191061
 Introduction

Biotech consortium India ltd , New Delhi.

Public Ltd company established in 1990 ,under the
companies Act , 1956.
Promoted by DBT , GOI.
Financed by all india financial institutions including
IDBI , ICICI, UTI , IFCI and some other corporate
sectors like ranbaxy labs , glaxo india, cadila lab ,
etc.
2
 Board of Directors of BCIL
Senior representative of DBT (Department of Biotechnology)
Council of Scientific and Industrial Research
Indian Council of Agricultural research
All leading Indian Financial Institutions
The biotechnology Industry

. Different schemes and programs are organized and conducted by BCIL :

Biotechnology industry paternship program
Biotechnology industry training program
Small business innovation research institute

3
BCIL'S Unique Strength & Objective
Promoted by DBT for facilitating commercialization of biotechnolog
Extensive experience and expertise in technology evaluation, packaging and transfer
CSIR & ICMR and other in-house subject expertise for guidance
Valuable resource base of subject specific experts from industry and academia
Close linkage with IPR experts
Competent and established law firms empanelled to assist BCIL in drafting, filling and prosecution
of patent applications

OBJECTIVE
Spearheading biotechnological commercialization in the areas of vaccines, diagnostics, recombinant
therapeutics, bio-fertilizers, biopesticides etc.
Efforts in transfer of technology and it's commercialization by the licensee and continues to be a
link between the technology tranferee and technology recipient.

4
 Functions of BCIL
1. Major function include development and transfer of technology for
commercialization of biotech products and human resource development.
2. Provide necessary linkages among stake holders including industries, R &
D institutions, Government and business support for facilitating access to
technologies.
3. They act as an interface between technology sources and technology
seekers both within and outside the country.
4. Create awareness about business opportunities, IPR protection and
biosafety requirements.
5. They facilitate regulatory approvals and provide human resources to
companies and assist in marketing tie ups.
6. They are actively involved in project consultancy , fund transfer,
information dissemination, training and placement related to
biotechnology. 5
 Range of Services at BCIL
IP management services
BCIL provides a comprehensive range of services for effective management of

Intellectual Property Rights (IPRs) to academia, research institutions, government

organizations, industry and start-ups in biotechnology and allied subject areas.

IP Analytics

BCIL undertakes assignments on IP analytics that includes different types of

searches for prior art i.e. scientific and technical information that exists prior to the
effective date of a patent application and preparation of comprehensive reports.

Based on the objective of assessing the prior art, it may be classified as:

Prior Art Search

Novelty and Patentability Search
Freedom-to-Operate.
Patent Landscape Analysis
State-of-the-Art Search
Invalidation/ Opposition Search 6
IP Advisory

BCIL advises clients for effective management of IPRs including providing opinion on best mode and jurisdictions for IP
protection and patent portfolio management.
Advisory on disclosure/ publication of research findings for patentable research leads is also provided.
Clients are also advised on judicious maintenance of patents and other forms of IPR, issues of infringement, opposition
proceedings, suits, appeals, etc.
National Biodiversity Authority (NBA) approval for filing of patent applications on bioresources: Stakeholders filing patent
applications on inventions utilising bioresources of Indian origin are required to seek approval from the NBA.

Filing, Prosecution and Maintenance of Patents and other IPR too

BCIL provides end-to-end services towards drafting, filing and prosecution of applications for different forms of IPR including
patents, trademarks, designs, copyrights and geographical indications in India and other jurisdictions.
BCIL ensures effective coordination at all the stages to ensure meeting the stringent time-lines of the procedural activities which
are crucial for ensuring successful grant and maintenance of patents and other forms of IPR.
BCIL facilitates registration of plant varieties under ‘The Protection of Plant Variety and Farmers Right Act, 2001’.

Capacity Building
BCIL undertakes projects on development and coordination of customized awareness programs, workshops and

hands-on-training sessions for different stakeholders including academia, research institutions, government

officials and industry in the following areas:

Intellectual Property Rights (IPR)
Access and Benefit Sharing (ABS)

7
Information Services:
it is engaged in collection, collation and analysis and dissemination of
commercially relevant biotech information.
major activities are:
biotech club
distributed information subcentre
conducting awareness program
developing new informative biotech related websites

Project Management:
provide services for technical, administrative and financial managementof long
term biotech projects
the projects for which management services are being offered include National
Biodiversity of Strategy and Action Plan (NBSAP)
8
 Biosafety Regulatory Support Services
Actively engaged in biosafety issues related to Genetically Modified Organisms
(GMOs) and new gene technologies.
Working closely with the nodal ministries and other concerned agencies.
Played a key role in developing guidelines, manuals, resource documents in India,
Sri Lanka and Bhutan.

REGULATORY
SERVICES
Clinical Development Support Services
Identification of suitable regulatory pathway for the new product taking into consideration -
Jurisdictions for marketing of the product
Waiver/exemption available as per current regulations
Minimum data compliance in view of approved products
Filing of (IND) application with the relevant regulatory authorities
Developing detailed plan for preclinical and clinical development and its implementation
conforming strictly to the timelines
End to end management of the study in a timeline-based manner for expedited product launch
9
 TECHNOLOGY TRANSFER

3 Decades of experience and expertise

60 technology transfers developed in India and abroad covering various domains of
biotechnology.

KEY CREDENTIALS
Thorough understanding of the product development cycle in all areas of biotechnology.
Systematic approach adopted by BCIL for identifying promising technologies, conducting
due diligence followed by transfer to suitable licence and post transfer monitoring.
Works closely with the research institutions and the industry for sharing market insights,
devising strategies for de-risking of technologies and catalyzing their evolution from
laboratory to market.
Subscription to state-of-the-art patent databases such as Thomson Innovation, Derwent
World Patent Index (DWPI), Asia Full-Text Patent Content and STN. 10
BCIL PROVIDES
TECHNOLOGY
TRANSFER
SERVICES TO THESE
LEADING
INSTITUTES IN
INDIA
To facilitate the transfer of indigenous technologies, Biotech Consortium India

TECHNOLOGY TRANSFER
Limited (BCIL) undertakes a methodical step-wise approach consisting of:
Technology Screening Technology Evaluation Technology Packaging

METHODOLOGY
commercial leads are Technology is Once technology appears
screened for
evaluated for
viable made
into a
technology assessment of its package facilitating the
formal technology commercial potential. entrepreneurs
transfer agreement is to access the commercial
executed with institute viability

Identification of
Technology Valuation Negotiations and Post transfer
potential Licensee
Based on many factors technology transfer monitoring
most critical step
including market

continuous
strategies
are adopted licence agreement is
demand, growth to ensure targeting of
monitoring
and
executed
potential, innovation the appropriate consultancy services.
of the technology potential segments.
12
TECHNOLOGY TRANSFER AT BCIL

13
 CONCLUSION
BCIL acts as an interface between technology sources and

technology seekers both within and outside the country.

By virtue of the network of national and international linkages
established by BCIL, it assists in technology sourcing ,marketing tie
ups and identification of joint venture partners

To facilitate the transfer of Technologies, BCIL undertakes a

methodical stepwise approach consisting for leads, technology
evaluation, validation, scale-up, packaging, technology pricing,
entrepreneur selection, technology transfer, monitoring, support and
consultancy

14
 Thank you

FOR
LISTENING

2022 November 14